Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Rayence Co., Ltd. (228850:KRX), powered by AI.
Rayence Co., Ltd. is currently trading at ₩6,710. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Rayence Co., Ltd. on Alpha Lenz.
Rayence Co., Ltd.'s P/E ratio is -21.1.
“Rayence Co., Ltd. trades at a P/E of -21.1 (undervalued) with modest ROE of -2.2%.”
Ask for details →Rayence Co., Ltd. specializes in the development and manufacture of digital X-ray imaging components and systems. The primary function of the company is to provide state-of-the-art radiographic solutions that enhance diagnostic capabilities across various medical fields. Rayence's product range includes flat panel detectors, radiography and fluoroscopy systems, which are integral in providing clear, precise imaging essential for accurate diagnosis and treatment planning. Operating predominantly in the healthcare sector, Rayence impacts medical institutions, hospitals, and clinics by offering cutting-edge imaging technology that also extends into dental, veterinary, and industrial applications. The company's innovative approach has led to the integration of advanced technologies like Artificial Intelligence to improve image processing and analysis. In the financial market, Rayence Co., Ltd. is recognized for its contributions to the medical equipment industry, which is an essential component of the global healthcare market. It plays a critical role in supporting medical professionals to deliver better patient outcomes through improved diagnostic tools. Headquartered in South Korea, Rayence continues to expand its international presence, addressing the growing demand for advanced medical imaging solutions.
“Rayence Co., Ltd. trades at a P/E of -21.1 (undervalued) with modest ROE of -2.2%.”
Ask for details →Rayence Co., Ltd. (ticker: 228850) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 228 employees. Market cap is $111.3B.
The current price is ₩6,710 with a P/E ratio of -21.08x and P/B of 0.47x.
ROE is -2.19% and operating margin is -3.44%. Annual revenue is $114.7B.